Hypnotherapy for irritable bowel syndrome in Saudi Arabian patients

View/ Open
Abstract
This study investigated whether hypnotherapy provides a significant therapeutic effect in Saudi Arabian patients with irritable bowel syndrome. Patients [n = 26] were consecutively recruited at a psychiatry outpatient clinic after diagnosis by a gastroenterologist and a medical evaluation for irritable bowel syndrome. Each patient had 12 sessions of hypnotherapy over a period of 12 weeks [1 session per week]. Patients completed a scale measuring symptom severity before and 3 months after the trial. Hypnotherapy significantly enhanced a feeling of better quality of life more in male than in female patients, and bowel habit dissatisfaction was reduced more in female than in male patientsCitation
Al Sughayir, M.A. (2007). Hypnotherapy for irritable bowel syndrome in Saudi Arabian patients. http://www.who.int/iris/handle/10665/117274
Relation
EMHJ - Eastern Mediterranean Health Journal, 13 (2), 301-308, 2007
Description
301-308ISSN
1020-3397Other Identifiers
http://applications.emro.who.int/emhj/1302/13_2_2007_301_308.pdfCollections
Language
EnglishMetadata
Show full item recordRelated items
Showing items related by title and MeSH subject.
-
Linaclotide: approved for irritable bowel syndrome
Unknown author (2012) -
Expanded Programme on Immunization (EPI) : Association between measles infection and the occurrence of chronic inflammatory bowel disease = Programme élargi de vaccination (PEV) : Association entre l’infection par le virus de la rougeole et la survenue d’une maladie inflammatoire chronique de l’intestin
World Health Organization (1998) -
HLA antigens and inflammatory bowel disease in a sample of Iraqi patients
Ad'hiah, A.H.; Jasim, H.A.; Fadhil, A.M.A. (2008)This study investigated the association between HLA antigens and inflammatory bowel disease in 65 Iraqi patients [50 ulcerative colitis, 15 Crohn disease] compared with 67 matched controls. At HLA class I region, the patients showed significantly increased frequencies of A9 and B41 and a decrease of A11. Similar results were found when the clinical types were considered separately, except for A11, which was not significant. At HLA class II region, DR8 was significantly increased in the total patients, but the association was not maintained for ...